Generate Biomedicines, Inc.
NASDAQ:GENBAsset Management
Financial Services
$10.38 +0.91%
+$0.13 today
- Market cap
- $1.34B
- Beta
- 0.19
- P/E (TTM)
- -3.5
- EPS (TTM)
- -$4.06
52W Low $11.00High $16.75
Volume 1.05M
Average 0.55M
Price history
Generate Biomedicines, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-17.94%
Period high
$20.38
Period low
$9.84
Latest
$10.38
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| SC 13G | Nov 5, 2026 | Nov 5, 2026 | |
| 4 | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Sep 3, 2026 | Sep 3, 2026 | |
| 144 | Sep 2, 2026 | Sep 2, 2026 | |
| 144 | Sep 1, 2026 | Sep 1, 2026 | |
| 8-K | Aug 26, 2026 | Aug 25, 2026 | |
| 10-Q | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Aug 6, 2026 | Aug 6, 2026 | |
| SC 13G | May 15, 2026 | May 15, 2026 | |
| SC 13G | May 15, 2026 | May 15, 2026 | |
| 10-Q | May 7, 2026 | May 7, 2026 | |
| 8-K | May 7, 2026 | May 7, 2026 | |
| 3 | Mar 12, 2026 | Mar 12, 2026 |
Competitors
Who does Generate Biomedicines, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about GENB's filings, answered from its disclosures.
What is the latest GENB filing?
The latest filing shown is 10-Q dated Nov 12, 2026.
How many recent filings does GENB have?
Intrinsic Alpha currently shows 20 recent filings for GENB.
Continue the stock analysis
Jump to another research area for this company.